Yohannes Haile
Hello, I am Yohannes in this conference I will present how we developed the Ethiopian assessment the Ethiopian Cognitive Assessment battery in Schizophrenia. Dr Habtamu, Dr Cella, and Professor Alem are other research members.
Cognitive impairment is common in people with schizophrenia, almost all people with schizophrenia that is 98% of them showed cognitive decrement compared to their premorbid status. Compared to healthy controls people with schizophrenia showed one to two standard deviations bellow the normative ee mean and this impairment is seen in people with schizophrenia who are not taking antipsychotics. And cognition is associated with poor personal, social, and treatment outcomes.
However, most of the available measures have been developed in west count in Western countries and they are not always well well adapted for use in low-income ee seating and norms are also doesn’t exist in these seatings. When we come to Ethiopia none of ee those measures has been validated for use in people with schizophrenia before. Hence, this study aims at filling ee this gap.
And when we come when we see the main findings; we developed ECAS by sleeting different tests from different batteries to address ee six main domains of cognition that we thought will be impaired in people with schizophrenia. And we found that ee ECAS is a promising tool in terms of feasibility with short duration of administration ee and p practicality and tolerability and with high inter-rater, test retest, and ee small practice effect. And with good ee validity in terms of structural validity and known-group validity. And finally, the item response theory-based analysis showed that the tool best function among participants with moderate impairment.
Thank you
